Repligen Corp

NAS:RGENHealthcareNASDAQ:NQUSMGSTOXX:EDD24BP

$176.43+0.58%At closeAt close · Tue 20 Oct · ≈ AED 647.94 · Market cap $11.2B · Next earnings Tue 27 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	53.1%	58.3%	56.9%	44.0%	43.3%	47.1%	—	—
Operating margin	22.2%	24.9%	28.0%	7.5%	−5.5%	8.1%	8.1%	+0.0 pts
Net margin	16.4%	19.1%	23.2%	5.6%	−4.0%	6.6%	6.6%	+0.0 pts
EBITDA margin	26.9%	30.3%	34.6%	23.0%	12.7%	22.3%	—	—
Return on equity	3.9%	7.3%	9.7%	1.8%	−1.3%	2.3%	2.3%	+0.0 pts
Return on assets	3.1%	5.4%	7.3%	1.3%	−0.9%	1.7%	1.7%	+0.0 pts
Return on capital employed	5.1%	8.4%	10.6%	1.8%	−1.3%	2.1%	—	—
Debt / equity	0.2×	0.2×	0.2×	0.4×	0.3×	0.3×	0.3×	+0.0%
Debt / assets	14.5%	15.5%	16.7%	25.1%	24.3%	23.4%	—	—
Interest coverage	6.7×	13.2×	75.5×	4.8×	−1.6×	2.6×	—	—
Current ratio	2.8×	2.5×	2.5×	6.7×	8.4×	8.4×	8.4×	+0.0%
Quick ratio	2.5×	2.0×	1.9×	5.5×	7.3×	7.1×	—	—
Cash ratio	2.2×	1.6×	1.3×	4.6×	6.0×	4.2×	4.2×	+0.0%
Asset turnover	0.2×	0.3×	0.3×	0.2×	0.2×	0.3×	—	—
Inventory turnover	1.8×	1.5×	1.5×	1.7×	2.5×	2.3×	—	—
Receivables turnover	5.1×	5.7×	6.9×	5.1×	4.7×	4.7×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.